Blood Transfusion Diagnostics Market Analysis

  • Report ID: 4481
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Segmentation:

Application 

The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2035. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.

End-user 

The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2035. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.

Our in-depth analysis of the global market includes the following segments:

      By Product Type

  • Instruments
  • Reagents & Kits

       By Application

  • Blood Group Typing
  • Blood Screening

        By End-User

  • Hospital Based Laboratories
  • Blood Banks

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood transfusion diagnostics is evaluated at USD 5.64 Billion.

The global blood transfusion diagnostics market size was worth more than USD 5.35 Billion in 2025 and is poised to witness a CAGR of over 6.1%, crossing USD 9.67 Billion revenue by 2035.

The North America blood transfusion diagnostics market will hold over 41% share by 2035, attributed to high accident rates and COVID-19 related blood supply disruptions.

Key players in the market include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos